Literature DB >> 31753144

Vascular cognitive impairment: A preventable component of dementia.

Mahmoud Reza Azarpazhooh1, Vladimir Hachinski2.   

Abstract

For many decades during the 20th century, the common belief was that the slow strangulation of the brains' blood supply from hardening of the brain arteries led to chronic brain ischemia and neuronal death. Not surprisingly, to counter this, vasodilators rapidly became one of the most commonly used and profitable medications worldwide; however, no clinical benefits were ever proven. In the 1970s and early 1980s cerebral blood flow studies strongly disproved the idea of brain failure due to chronic ischemia. It was also shown that infarcts and not chronic ischemia caused dementia, leading to the concept of multiinfarct dementia. In addition to infarcts, it was then realized that other vascular lesions can also cause cognitive decline. Gradually, as "atherosclerotic dementia" lost ground, Alzheimer's disease (AD) that once had been considered a presenile dementia and rare, became almost synonymous with dementia. Subsequent memory-based definitions and evaluations of dementia led to a bias in favor of diagnosing AD, overshadowing vascular contributions. The widespread use of brain imaging in the 1980s and 1990s contributed to the resurgence of evidence of cerebrovascular diseases. Moreover, it was shown that most cognitive impairment of the elderly results from mixed pathologies, emphasizing the need for a change in the traditional categorical diagnosis of dementia, e.g., AD vs vascular dementia. The alternative diagnostic method was named the vascular cognitive impairment approach, meaning identifying any impairment caused by or associated with vascular factors. The importance of this approach is that vascular lesions are currently the most important treatable and preventable components of dementia, even before any symptoms manifest, i.e., at the brain at risk stage. This chapter provides a summary of the vascular cognitive impairment approach to diagnosis, treatment, and prevention of cognitive decline.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognition; Cognitive decline; Dementia; Prevention; Stroke; Vascular cognitive impairment; Vascular dementia; Vascular lesions

Mesh:

Year:  2019        PMID: 31753144     DOI: 10.1016/B978-0-12-804766-8.00020-0

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  6 in total

1.  Mineralocorticoid receptor antagonism improves transient receptor potential vanilloid 4-dependent dilation of cerebral parenchymal arterioles and cognition in a genetic model of hypertension.

Authors:  Laura C Chambers; Janice M Diaz-Otero; Courtney L Fisher; William F Jackson; Anne M Dorrance
Journal:  J Hypertens       Date:  2022-09-01       Impact factor: 4.776

2.  The microstructural abnormalities of cingulum was related to patients with mild cognitive impairment: a diffusion kurtosis imaging study.

Authors:  Yueyang Liu; Dongtao Liu; Mingyong Liu; Kun Li; Qinglei Shi; Chenlong Wang; Zhenyu Pan; Lichun Zhou
Journal:  Neurol Sci       Date:  2022-09-28       Impact factor: 3.830

3.  Correlation of serum uric acid, cystatin C and high-sensitivity C-reactive protein with cognitive impairment in lacunar cerebral infarction.

Authors:  Fenfei Wanggong; Jianfeng Xiang; Shichen Yang; Weilan Zhang; Reziya Tuerganbieke
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

4.  Estrogen Exerts Neuroprotective Effects in Vascular Dementia Rats by Suppressing Autophagy and Activating the Wnt/β-Catenin Signaling Pathway.

Authors:  Yanyan Yang; Lei Zhao; Na Li; Congwei Dai; Nan Yin; Zhaoping Chu; Xiaoyan Duan; Xiaoli Niu; Ping Yan; Peiyuan Lv
Journal:  Neurochem Res       Date:  2020-07-27       Impact factor: 4.414

5.  Exploring the Effect of Enbrel Softgels on PWI Indicators in VCIND Patients.

Authors:  Lei Cui; Pan Li; Jingchen Zhang; Xiaofang Li
Journal:  J Healthc Eng       Date:  2022-04-06       Impact factor: 2.682

Review 6.  Evaluation and Treatment of Vascular Cognitive Impairment by Transcranial Magnetic Stimulation.

Authors:  Mariagiovanna Cantone; Giuseppe Lanza; Francesco Fisicaro; Manuela Pennisi; Rita Bella; Vincenzo Di Lazzaro; Giovanni Di Pino
Journal:  Neural Plast       Date:  2020-10-27       Impact factor: 3.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.